Tag: CBT > Preclinical Medical Cannabis Research: Page 2

International

Global Companies Expand Work on Cannabis-Based Epilepsy Treatments

Representatives of companies with global footprints discuss the goals behind the research, governmental approval and sale of cannabis compounds for epileptic conditions.

December 3, 2021

Legislation and Regulation

Industry Weighs in on DEA Cannabis Research Final Rule

Stakeholders express concern that the agency will weigh applicants’ compliance with federal law when granting registrations.

December 23, 2020

Finance

R&D Tax Credit: A Viable Option to Reduce Tax Burdens?

Proper planning and corporate structuring can help cannabis and hemp companies find tax savings despite 280E restrictions.

December 3, 2020

Legislation and Regulation

NIDA Releases Request for Information on THC Dosing Standards

The National Institute of Drug Abuse has issued a request for comments on establishing and implementing a standard unit of dosage for THC in order to improve cannabis research efforts.

March 30, 2020

International

New Research Looks at Hemp-Sourced Cannabinoid, CBM

Recent research by a team of Italian scientists examined the minor cannabinoid known as cannabimovone and its ability to engage with a receptor type that helps regulate both metabolic and immune functions with implications for future investigation into its use in the treatment of a variety of disease states.

March 6, 2020

International

CBN, CBC and Acidic Forms Found to Kill Colon Cancer Cells

A new pre-clinical study from Cannabics Pharmaceuticals finds CBN, CBC and their acidic forms to be effective against human colon cancer cell lines.

February 21, 2020

Hemp Research

How CBG Can Alleviate Common Symptoms of Cancer Treatment

Preliminary studies have shown how CBG attacks cancer cells, but this minor cannabinoid may improve chemotherapy-related symptoms and quality of life for cancer patients as well.

February 19, 2020

Top Stories

CBG: A New(er) Option for Cancer Treatment?

Preliminary studies show promise of a non-intoxicating stem cell cannabinoid against cancer cell lines in both isolated and synergistic drug preparations.

February 6, 2020

International

CBG and CBC Kill Gastrointestinal Cancer Cells in Preliminary Study

Funded by U.S. company Cannabics Pharmaceuticals, a firm focused on the development of cannabinoid therapies for cancer treatment, Israeli researchers have demonstrated the anti-tumor efficacy of CBG and CBC against human gastrointestinal cancer cell lines.

January 27, 2020

International

Super Drugs for Superbugs: How Cannabinoid Science Links CBG to MRSA Treatment

For nearly 40 years, the antimicrobial effects of cannabis-sourced compounds have been known to researchers. A new study sheds light on the particularly potent efficacy of an up-and-coming cannabinoid, CBG.

January 24, 2020

Industry Headlines

Cannabis Flavonoid Derivative May Offer Hope for Pancreatic Cancer Patients

Recent research has demonstrated the therapeutic potential of a flavonoid found in cannabis in the treatment of invasive pancreatic cancer, and clinical trials using a derivative of this flavonoid are set to start in spring.

January 21, 2020